AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sibulesky, L.
Right arrow Articles by Berson, E. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sibulesky, L.
Right arrow Articles by Berson, E. L
Agricola
Right arrow Articles by Sibulesky, L.
Right arrow Articles by Berson, E. L
American Journal of Clinical Nutrition, Vol. 69, No. 4, 656-663, April 1999
© 1999 American Society for Clinical Nutrition


Original Research Communications

Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa1,2,3

Lena Sibulesky, KC Hayes, Andrzej Pronczuk, Carol Weigel-DiFranco, Bernard Rosner and Eliot L Berson

Background: Vitamin A supplementation is being used successfully to treat some forms of cancer and the degenerative eye disease retinitis pigmentosa. The daily biological need for vitamin A is estimated to be 800 retinol equivalents (RE)/d (2667 IU/d) for adult women and 1000 RE/d (3300 IU/d) for adult men; doses >=7500 RE (>=25000 IU)/d are considered potentially toxic over the long term.

Objective: We assessed the safety in adults of long-term vitamin A supplementation with doses above the daily biological need but <7500 RE (<25000 IU)/d.

Design: Adults aged 18–54 y with retinitis pigmentosa but in generally good health (n = 146) were supplemented with 4500 RE (15000 IU) vitamin A/d for <=12 y (group A) and compared with a similar group (n = 149) that received 23 RE (75 IU)/d (trace group). Mean total consumption of vitamin A in group A was 5583 RE (18609 IU)/d (range: 4911–7296 RE/d, or 16369–24318 IU/d) and that in the trace group was 1053 RE (3511 IU)/d (range: 401–3192 RE/d, or 1338–10638 IU/d).

Results: Patients in group A showed an 8% increase in mean serum retinol concentration at 5 y and an 18% increase at 12 y (P < 0.001); no retinol value exceeded the upper normal limit (3.49 µmol/L, or 100 µg/dL). Mean serum retinyl esters were elevated {approx}1.7-fold at 5 y and remained relatively stable thereafter. No clinical symptoms or signs of liver toxicity attributable to vitamin A excess were detected.

Conclusions: Prolonged daily consumption of <7500 RE (<25000 IU) vitamin A/d can be considered safe in this age group.

Key Words: Vitamin A • supplementation • triacylglycerols • liver enzymes • retinal degeneration • retinitis pigmentosa • retinol • adults




This article has been cited by other articles:


Home page
Arch OphthalmolHome page
E. L. Berson, B. Rosner, M. A. Sandberg, C. Weigel-DiFranco, A. Moser, R. J. Brockhurst, K. C. Hayes, C. A. Johnson, E. J. Anderson, A. R. Gaudio, et al.
Clinical Trial of Docosahexaenoic Acid in Patients With Retinitis Pigmentosa Receiving Vitamin A Treatment
Arch Ophthalmol, September 1, 2004; 122(9): 1297 - 1305.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
N. D. Radtke, R. B. Aramant, M. J. Seiler, H. M. Petry, and D. Pidwell
Vision Change After Sheet Transplant of Fetal Retina With Retinal Pigment Epithelium to a Patient With Retinitis Pigmentosa
Arch Ophthalmol, August 1, 2004; 122(8): 1159 - 1165.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. D. Dawson, Y. Yamamoto, R. Zolfaghari, F. J. Rosales, J. Dietz, T. Shimada, N.-q. Li, and A. C. Ross
Regulation of Hepatic Vitamin A Storage in a Rat Model of Controlled Vitamin A Status during Aging
J. Nutr., May 1, 2000; 130(5): 1280 - 1286.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The American Society for Nutrition